<CodeList xmlns="http://www.cdisc.org/ns/odm/v1.3" xmlns:nciodm="http://ncicb.nci.nih.gov/xml/odm/EVS/CDISC" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" OID="CL.C99076.INTMODEL" Name="Intervention Model Response" DataType="text" nciodm:ExtCodeID="C99076" nciodm:CodeListExtensible="Yes">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the trial design developed to compare treatment groups.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="CROSS-OVER" nciodm:ExtCodeID="C82637">
                    <nciodm:CDISCDefinition>Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Crossover Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FACTORIAL" nciodm:ExtCodeID="C82638">
                    <nciodm:CDISCDefinition>Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Factorial Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PARALLEL" nciodm:ExtCodeID="C82639">
                    <nciodm:CDISCDefinition>Participants are assigned to one of two or more treatment groups in parallel for the duration of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Parallel Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SEQUENTIAL" nciodm:ExtCodeID="C142568">
                    <nciodm:CDISCDefinition>Groups of participants are assigned to receive interventions based on prior milestones being reached in the study. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Group Sequential Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SINGLE GROUP" nciodm:ExtCodeID="C82640">
                    <nciodm:CDISCDefinition>All trial participants are assigned to a single treatment group for the duration of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Single Group Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>INTMODEL</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Intervention Model Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Intervention Model Terminology</nciodm:PreferredTerm>
            </CodeList>
            
